Rise and shine, everyone, another day is on the way. And this looks to be a soggy one, unfortunately. Nonetheless, our spirits are sunny. And why not? To celebrate our continued existence, we are using our shiny new coffee kettle to brew that treasured cup of stimulation. Our flavor today is Wild Mountain Blueberry. Do join us. Meanwhile, we have gathered some tidbits for your edification. Hope your day goes well and stay in touch...
FDA Cites Blood Clot Risks With Bayer Contraceptives (Bloomberg News)
Boehringer Says Pradaxa Patients Need Kidney Checks (Reuters)
Gardasil Sales May Not Grow, Despite Recommendation For Boys (Bloomberg News)
Flu Vaccines Should Be Updated, A New Study Finds (Reuters)
FDA Delays Decision On Bristol, Astra Diabetes Drug (Associated Press)
Pfizer And Medco Strike Personalized Medicine Deal (Reuters)
Generic API Makers To Most Of GDUFA Fees (InPharma Technologist)
Gilead And Bristol Sign Deal For HIV Agent (San Francisco Business Times)
Bayer Third-Quarter Earnings Rise On Emerging Market Sales (Bloomberg News)
AstraZeneca Quarterly Profit Helped By Asset Sale (Associated Press)
New Jersey Employee Fund Sues Pfizer Over Effexor Patent Delay (The Record)
Teva Stock Hits Two-Month High Due To Cheap Valuation (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates throughout the morning
rain pic thx to sterlic on flickr
1 Comment
The Wild mountain blueberry sounds wonderful. Here it is Maxwell House (regular or decaf) ... so I will just envy you.